IL2 and systemic lupus erythematosus: Meta‐analysis of three observational studies, including 92 patients with SLE, showed that the SRI‐4 response rate of patients treated with LD‐IL‐2 after 12 weeks was 0.819 (95% confidence interval [CI]: 0.745–0.894) (Figure 2A).